Stage 1 Mesothelioma News
- Exelixis Reports Positive Phase 1 Data for PI3K/mTOR Inhibitor XL765 at EORTC-NCI-AACR Symposium Wednesday, October 22, 2008 @ 6:19AMExelixis, Inc. (Nasdaq:EXEL) today reported interim data from a phase 1 dose-escalation trial of XL765, a novel small molecule inhibitor of PI3K and mTOR, which are implicated in tumor cell proliferation, survival, and resistance to chemotherapy and radiotherapy. The trial is being carried out in patients with metastatic or unresectable solid tumors for which known effective measures do not ...
- Exelixis Reports Positive Phase 1 Data for PI3K/mTOR Inhibitor XL765 at EORTC-NCI-AACR Symposium Wednesday, October 22, 2008 @ 6:00AM GENEVA----Exelixis, Inc. today reported interim data from a phase 1 dose-escalation trial of XL765, a novel small molecule inhibitor of PI3K and mTOR, which are implicated in tumor cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
- EPA: Mill brims with toxins Thursday, October 16, 2008 @ 10:07AMPhoto by Rick EpsteinGRIMLY DETERMINED, Milford Mayor Jim Gallos wants the old paper mill site secured, cleaned up and redeveloped in a reasonable way. With the EPA interested in the cleanup, he may eventually get his wish. MILFORD -- The...
- UK news in brief Sunday, August 24, 2008 @ 7:12PMMore news from around the UK
- Lung Cancer Studies Earn Prestigious Award Sunday, August 10, 2008 @ 4:04AMShahriyour Andaz, MD, FACS, FRCS, Director of Thoracic Oncology at South Nassau Communities Hospital, is the co-author of two studies that earned honors at the Brooklyn and Long Island Chapter of the American College of Surgeons Murry Friedman Surgical Resident Competition.
- JapanToday : Japan News and Discussion ジャパントゥデイ:日本のニュースを英語で読む Monday, July 14, 2008 @ 8:47PMWhen one thinks of Oji Paper, Japan’s largest paper manufacturing company (in terms of consolidated sales), the image is of vast green forests in Hokkaido, excellent paper-making technology, and the guiding hand of Eichi Shibusawa.
- JapanToday : Japan News and Discussion ジャパントゥデイ:日本のニュースを英語で読む Monday, July 14, 2008 @ 8:47PMWhen one thinks of Oji Paper, Japan’s largest paper manufacturing company (in terms of consolidated sales), the image is of vast green forests in Hokkaido, excellent paper-making technology, and the guiding hand of Eichi Shibusawa.
- JapanToday : Japan News and Discussion ジャパントゥデイ:日本のニュースを英語で読む Monday, July 14, 2008 @ 8:47PMWhen one thinks of Oji Paper, Japan’s largest paper manufacturing company (in terms of consolidated sales), the image is of vast green forests in Hokkaido, excellent paper-making technology, and the guiding hand of Eichi Shibusawa.
- JapanToday : Japan News and Discussion ジャパントゥデイ:日本のニュースを英語で読む Monday, July 14, 2008 @ 8:47PMWhen one thinks of Oji Paper, Japan’s largest paper manufacturing company (in terms of consolidated sales), the image is of vast green forests in Hokkaido, excellent paper-making technology, and the guiding hand of Eichi Shibusawa.
- JapanToday: Japan News and Discussion ジャパントゥデイ:日本のニュースを英語で読む Monday, July 14, 2008 @ 8:47PMWhen one thinks of Oji Paper, Japan’s largest paper manufacturing company (in terms of consolidated sales), the image is of vast green forests in Hokkaido, excellent paper-making technology, and the guiding hand of Eichi Shibusawa.
- Alfacell Reports Financial Results for Third Quarter of Fiscal 2008 Monday, June 9, 2008 @ 8:30AM Alfacell Corporation today reported its financial results for the third quarter of fiscal 2008.
- CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc. Monday, June 9, 2008 @ 5:30AM LOS ANGELES----CytRx Corporation , a biopharmaceutical company engaged in the development and commercialization of therapeutics based on molecular chaperone amplification technology, today announced the signing of a definitive agreement to purchase Innovive Pharmaceuticals, Inc., a publicly traded biopharmaceutical company with four clinical stage oncology drug candidates.
- Alfacell to Host Fiscal Third Quarter 2008 Financial Results Conference Call and Webcast Wednesday, June 4, 2008 @ 8:30AM Alfacell Corporation today announced that it will host a conference call and Webcast at 11 a.m. EDT on Monday, June 9.
- Washington DC Tuesday, June 3, 2008 @ 11:27AMNEW YORK , June 3 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today announced that phase 2 results of perifosine (KRX-0401) in patients with relapsed/refractory Waldenstroms macroglobulinemia (WM) was presented at the 44th Annual Meeting of the American Society of Clinical Oncology.
- Washington DC Saturday, May 31, 2008 @ 4:27PMCHICAGO , May 31 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL ) reported interim data from a phase 1 dose-escalation trial of XL765, a novel small molecule inhibitor of phosphoinositide-3 kinase (PI3K) and mTOR, which are implicated in tumor cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
- People power against plant Tuesday, May 27, 2008 @ 9:29PMIT’S a resounding ‘No’ to the proposed peaking power plant at Herons Creek, say the people of the Camden Haven.
- Carbon nanotubes: the new asbestos? Tuesday, May 20, 2008 @ 5:26PMCalls for caution as nanotubes cause precancerous growths in mice.
- Lung cancer patients live longer with Alimta -study Thursday, May 15, 2008 @ 9:15PM Source: Reuters (Recasts, adds study details, doctor comment, background) By Maggie Fox, Health and Science Editor WASHINGTON, May 15 (Reuters) - Adding a little extra chemotherapy after finishing the initial ...
- Alfacell to Host Fiscal First Quarter 2008 Financial Results Conference Call and Webcast Monday, December 3, 2007 @ 8:30AM Alfacell Corporation today announced that it will host a conference call and Webcast at 11 a.m. EST on Monday, Dec. 10.
